CFO
TRAK icon

Callan Family Office’s ReposiTrak TRAK Stock Holding History

Callan Family Office’s Portfolio TRAK Stock Details TRAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90K Buy
+10,001
New +$91.4K ﹤0.01% 1181

Other funds holding TRAK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $933M AUM 56.2% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Callan Family Office's TRAK Position: Q2 2026 in Review

Callan Family Office opened a new position in ReposiTrak (TRAK) in Q2 2026: 10,001 shares worth $90K. The stake represents ﹤0.01% of the portfolio and ranks #1181 among its holdings.

116 funds tracked by Wall St. Rank hold TRAK as of Q2 2026.

  • Callan Family Office held 10,001 shares of ReposiTrak worth $90K as of Q2 2026.
  • ReposiTrak was a new Callan Family Office position in Q2 2026.
  • ReposiTrak made up ﹤0.01% of Callan Family Office's portfolio in Q2 2026, its #1181 holding.
  • 116 funds tracked by Wall St. Rank held ReposiTrak as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.